ArticleBMC endocrine disorders2026
Accelerated biological aging is associated with the negative relationship between dietary intake of live microbes and diabetic retinopathy in US diabetic patients.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the association between dietary live microbe intake and diabetic retinopathy (DR), and explore whether accelerated biological aging is linked to this association.
methodsUsing data from National Health and Nutrition Examination Survey 2005-2018 2279 participants were categorized into low/medium/high live microbe intake groups and MedHi food intake groups (G1/G2/G3). Weighted logistic regression, weighted restricted cubic spline (RCS) and mediation analysis were performed to assess associations with DR. Subgroup analysis and sensitivity analysis were conducted to verify the robustness of the main study results.
resultsHigher live microbe intake was associated with lower DR risk: medium (OR = 0.65; 95%CI = 0.45-0.96; p = 0.029) and high (OR = 0.58; 95%CI = 0.38-0.90; p = 0.015) groups vs. low; G2(OR = 0.60; 95%CI = 0.36-0.97; p = 0.039) and G3 (OR = 0.64; 95%CI = 0.43-0.95; p = 0.026) vs. G1. RCS analysis revealed a nonlinear dose-response with an inflection point at 262.86 g/day. PhenoAge (PA) acceleration, Klemera-Doubal Method-Biological Age (KDM-BA) acceleration, and HbA1c were associated with 14.7%, 13.4%, and 8.3% of the relationship for high live microbe intake, and 12.6%, 13.9%, and 8.3% for G3, respectively. Subgroup analysis showed that the association between dietary live microbe intake and DR was generally consistent across subgroups of age, race, BMI, etc. with a significant interaction only in the sex subgroup (P for interaction = 0.02). Sensitivity analysis confirmed the robustness of the main study results.
conclusionsDietary live microbe intake is inversely associated with DR, with biological aging and glycemic control potentially linked to this relationship. Increasing intake of live microbe-rich foods may be correlated with reduced DR risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.